CareDx, Inc. Common Stock CDNA
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-11T14:06:18.569Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T13:59:31.692072782Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T14:06:15.781074+00:00
CareDx, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 97.65 | 113.4% | 20.4% | 72.48 | 106.0% | 14.1% |
| 25Δ | 75.44 | 94.3% | 10.9% | |||
| 30Δ | 87.41 | 58.7% | 7.7% | 77.17 | 91.0% | 9.4% |
| 35Δ | 85.87 | 55.1% | 6.1% | 78.89 | 87.7% | 7.8% |
| 40Δ | 84.62 | 53.0% | 4.9% | 80.52 | 86.3% | 6.6% |
| 45Δ | 83.74 | 52.8% | 4.4% | 82.00 | 88.2% | 5.9% |
| 50Δ | 82.87 | 52.6% | 3.8% | 83.47 | 90.1% | 5.1% |
| 55Δ | 82.00 | 52.4% | 3.3% | 84.94 | 92.0% | 4.4% |
| 60Δ | 81.12 | 52.2% | 2.7% | 86.77 | 94.0% | 3.8% |
| 65Δ | 80.25 | 52.0% | 2.1% | 88.61 | 96.0% | 3.2% |
| 70Δ | 79.42 | 49.5% | 1.8% | 90.83 | 99.8% | 2.6% |
| 75Δ | 78.62 | 46.1% | 1.5% | 94.15 | 109.2% | 2.2% |
| 80Δ | 77.81 | 42.7% | 1.1% | 98.97 | 122.5% | 1.8% |
20Δ
- Pseudo strike
- 97.65
- IV
- 113.4%
- B/E move
- 20.4%
- Pseudo strike
- 72.48
- IV
- 106.0%
- B/E move
- 14.1%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 75.44
- IV
- 94.3%
- B/E move
- 10.9%
30Δ
- Pseudo strike
- 87.41
- IV
- 58.7%
- B/E move
- 7.7%
- Pseudo strike
- 77.17
- IV
- 91.0%
- B/E move
- 9.4%
35Δ
- Pseudo strike
- 85.87
- IV
- 55.1%
- B/E move
- 6.1%
- Pseudo strike
- 78.89
- IV
- 87.7%
- B/E move
- 7.8%
40Δ
- Pseudo strike
- 84.62
- IV
- 53.0%
- B/E move
- 4.9%
- Pseudo strike
- 80.52
- IV
- 86.3%
- B/E move
- 6.6%
45Δ
- Pseudo strike
- 83.74
- IV
- 52.8%
- B/E move
- 4.4%
- Pseudo strike
- 82.00
- IV
- 88.2%
- B/E move
- 5.9%
50Δ
- Pseudo strike
- 82.87
- IV
- 52.6%
- B/E move
- 3.8%
- Pseudo strike
- 83.47
- IV
- 90.1%
- B/E move
- 5.1%
55Δ
- Pseudo strike
- 82.00
- IV
- 52.4%
- B/E move
- 3.3%
- Pseudo strike
- 84.94
- IV
- 92.0%
- B/E move
- 4.4%
60Δ
- Pseudo strike
- 81.12
- IV
- 52.2%
- B/E move
- 2.7%
- Pseudo strike
- 86.77
- IV
- 94.0%
- B/E move
- 3.8%
65Δ
- Pseudo strike
- 80.25
- IV
- 52.0%
- B/E move
- 2.1%
- Pseudo strike
- 88.61
- IV
- 96.0%
- B/E move
- 3.2%
70Δ
- Pseudo strike
- 79.42
- IV
- 49.5%
- B/E move
- 1.8%
- Pseudo strike
- 90.83
- IV
- 99.8%
- B/E move
- 2.6%
75Δ
- Pseudo strike
- 78.62
- IV
- 46.1%
- B/E move
- 1.5%
- Pseudo strike
- 94.15
- IV
- 109.2%
- B/E move
- 2.2%
80Δ
- Pseudo strike
- 77.81
- IV
- 42.7%
- B/E move
- 1.1%
- Pseudo strike
- 98.97
- IV
- 122.5%
- B/E move
- 1.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 69.00% | |
| 69.98% | |
| 69.59% | |
| 71.87% | |
| 70.49% | |
| 71.05% | |
| 72.82% | |
| 70.57% | |
| 70.22% | |
| 54.21% |
Diagnostics & Research
CRL
Description unavailable
More →CSTL
Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests, particularly within the skin cancer sector,…
More →DGX
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains…
More →DHR
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional,…
More →FLGT
Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in…
More →GH
Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood…
More →